Question 1

What is SOMATROGON-GHLA used for?

Accepted Answer

SOMATROGON-GHLA (brand name Ngenla) is a Other indicated for See full prescribing information.

Question 2

How does SOMATROGON-GHLA work?

Accepted Answer

SOMATROGON-GHLA works through the following mechanism: 12.1 Mechanism of Action Somatrogon-ghla binds to the GH receptor and initiates a signal transduction cascade culminating in changes in growth and metabolism. Somatrogon-ghla binding leads to activation of the STAT5b signaling pathway and increases the serum concentration of Insulin-like Growth Factor (IGF-1). GH and IGF-1 stimulate metabolic changes, linear growth, and enhance growth velocity in pediatric patients with GHD..

Question 3

What are the most common side effects of SOMATROGON-GHLA?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for SOMATROGON-GHLA. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is SOMATROGON-GHLA the same as Ngenla?

Accepted Answer

Ngenla is a brand name for SOMATROGON-GHLA. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

SOMATROGON-GHLA

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations